Home
Life Sciences

Sector: Life Sciences

Huawei, Intel among big firms selling patents in June-recorded transactions

Two deals could bring NPE risk but others stem from bankruptcies, buying and selling of business units and company product collaborations

Historic moment as UPC hands down two full decisions within 24 hours of each other

The Unified Patent Court has handed patentees a win and a loss in its first on-the-merits rulings

Pharma patent litigation highlights in Southeast Asia in early 2020s

Rouse highlights some of the most important pharma patent decisions issued by Southeast Asian courts in the past four years

Latest content

The patent buyer behind IPA Technologies’ $242 million verdict

Michael Zhang, a former WiLAN associate vice president, talks about the verdict against Microsoft, his approach to licensing, and more

23 May 2024

Docket Navigator and IAM Litigation Report Q1 2024

Featured in Docket Navigator and IAM Litigation Report

In this edition, our team puts the magnifying glass to Docket Navigator data on the Patent Trial and Appeal Board – case filing trends, institution success, IPR outcomes, and party and firm rankings

22 May 2024

Pfizer unit awarded $108 million for AstraZeneca infringement by Delaware jury

But big money pharma patent damages have a habit of being overturned

21 May 2024

Moderna’s surprise EPO win is a boost for its flagging European patent assertions

But the covid-19 jab maker must overcome several more hurdles to get its hands on a slice of Pfizer/BioNTech’s vaccine revenues

20 May 2024

Amgen’s Sandoz settlement latest of many biosimilar dispute successes

Californian company has been one of the most prolific litigants on both sides of BPCIA disputes

16 May 2024

10x Genomics suffers another reversal of fortunes with German invalidation in NanoString spat

Following buyout by Bruker, NanoString has struck another blow in worldwide patent dispute against its spatial biology rival

13 May 2024

Time for CRISPR Cas9 patent enforcement approaching, says IP licensing chief on CVC side

ERS Genomics seeking to educate market on need to take a licence, says Michael Arciero, but litigation may soon be necessary

06 May 2024

Visiting Washington DC patent people filled me with optimism

Saturday Opinion: US Congress sentiment on patent reform has been swayed by national security concerns, Big Tech probes, and innovation stories that combat “patent troll” talk

04 May 2024

FTC opposes 300 more Orange Book patents

The US Federal Trade Commission is ramping up pressure on pharma patentees

02 May 2024

BREAKING: UPC grants preliminary injunction against Curio Bioscience

New court hands down its latest PI decision

30 April 2024

Unlock unlimited access to all IAM content